Novavax
NVAX
#5006
Rank
A$2.57 B
Marketcap
A$15.68
Share price
7.03%
Change (1 day)
36.98%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): A$0.75 Billion

According to Novavax's latest financial reports the company's current earnings are A$1.08 Billion. , an increase over its 2024 earnings that were of -A$0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 A$0.65 B-396.87%
2024 -A$0.22 Billion-70.39%
2023 -A$0.75 Billion-16.59%
2022 -A$0.89 Billion-62.58%
2021 -A$2.38 Billion320.54%
2020 -A$0.57 Billion234.22%
2019 -A$0.17 Billion-30.17%
2018 -A$0.25 Billion1.69%
2017 -A$0.24 Billion-36.44%
2016 -A$0.38 Billion70.4%
2015 -A$0.22 Billion89.27%
2014 -A$0.12 Billion59.83%
2013 -A$72.55 Million81.9%
2012 -A$39.89 Million50.33%
2011 -A$26.54 Million
2009 -A$52.36 Million8.8%
2008 -A$48.13 Million18.01%
2007 -A$40.79 Million18.33%
2006 -A$34.47 Million168.31%
2005 -A$12.85 Million-62.51%
2004 -A$34.27 Million52.4%
2003 -A$22.49 Million-28.21%
2002 -A$31.32 Million
2000 -A$17.85 Million177%
1999 -A$6.45 Million-11.54%
1998 -A$7.29 Million10.64%
1997 -A$6.59 Million-9.62%
1996 -A$7.29 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.10 B 3,296.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$14.83 B 2,179.04%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.53 B 3,055.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$14.02 B 2,054.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-A$0.99 Billion-251.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-A$0.41 Billion-161.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$28.94 M-95.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-A$11.39 Million-101.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A$0.37 B-42.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$0.23 B-64.43%๐Ÿ‡บ๐Ÿ‡ธ USA